Insider · CIK 0001124181
Jan Stern Reed
Files at SCL (STEPAN CO), ANGO (ANGIODYNAMICS INC), RCEL (AVITA Medical, Inc.). First filing -, latest -.
Jan Stern Reed files SEC Form 4 as director at SCL (STEPAN CO), and also at ANGO (ANGIODYNAMICS INC), RCEL (AVITA Medical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jan Stern Reed has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +22,214 | - | - | 73,225 | Jun 4, 2026 |
| Jan 20, 2026 | RCEL AVITA Medical, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +16,133 | $0.00 | $0 | 16,133 | Jun 4, 2026 |
| Jul 16, 2025 | ANGO ANGIODYNAMICS INC | AGrant or award Common Stock | +17,675 | $0.00 | $0 | 105,034 | Jul 18, 2025 |
| Jan 21, 2025 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +10,022 | - | - | 51,011 | Jun 5, 2025 |
| Jan 21, 2025 | RCEL AVITA Medical, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +4,295 | $0.00 | $0 | 4,295 | Jun 5, 2025 |
| May 12, 2025 | SCL STEPAN CO | AGrant or award Common Stock | +2,500 | $54.26 | $136k | 13,911 | May 13, 2025 |
Questions about Jan Stern Reed
Answered from the filings on this page, as of the latest one.
Is Jan Stern Reed buying or selling?
Jan Stern Reed has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jan Stern Reed's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jan Stern Reed has 0.
Where does Jan Stern Reed file Form 4?
Jan Stern Reed has filed Form 4 at SCL (STEPAN CO); ANGO (ANGIODYNAMICS INC); RCEL (AVITA Medical, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.